Lutz Edler

Update: use of the benchmark dose approach in risk assessment

Diane Benford, Michael Jeger, Katrine Helle Knutsen et al. · EFSA Journal · 2017 · 501 citations · Full text

Riskbenefit Ratio, Risk Management, Benchmark Dose +19

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Dirk Schadendorf, Selma Ugurel, Beatrice Schuler‐Thurner et al. · Annals of Oncology · 2006 · 466 citations · Full text

Cancer Immunosurveillance, Medicine, Melanoma +9

“ToxRTool”, a new tool to assess the reliability of toxicological data

Klaus Schneider, Markus Schwarz, Iris Burkholder et al. · Toxicology Letters · 2009 · 373 citations

Reliability, “ Toxrtool ”, Predictive Toxicology +15

Efficacy of Fractionated Stereotactic Reirradiation in Recurrent Gliomas: Long-Term Results in 172 Patients Treated in a Single Institution

Stephanie E. Combs, Christoph Thilmann, Lutz Edler et al. · Journal of Clinical Oncology · 2005 · 318 citations

Effectiveness of Carbon Ion Radiotherapy in the Treatment of Skull-Base Chordomas

Daniela Schulz–Ertner, Christian P. Karger, A. Feuerhake et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 289 citations

Neuro-oncology, Skull Base, Radiation Therapy +8